GSK Jan 2025 30.000 put
| Previous Close | 0.1500 |
| Open | 0.1500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 30.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.1500 - 0.1500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
Simply Wall St.GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
GSK plc's ( LON:GSK ) investors are due to receive a payment of £0.15 per share on 11th of July. The dividend yield...
GlobeNewswireBioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C financing round extended overall by CHF 12.3 million to CHF 44.9 million BASEL, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections
Investor's Business DailyGSK Stock Today: Buying An August Covered Call Boosts Your Return By This Much
A covered call strategy is one way to slightly reduce the risk on a long stock position while also generating some premium. Further upside in a covered call position in GSK stock is limited above the covered call strike. Let's look at how a covered call trade on GSK, formerly known as GlaxoSmithKline and based in the UK, might take shape.
